These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2280235

  • 1. Elevation of plasma neuropeptide Y-like immunoreactivity and noradrenaline during myocardial ischaemia in man.
    Ullman B, Franco-Cereceda A, Hulting J, Lundberg JM, Sollevi A.
    J Intern Med; 1990 Dec; 228(6):583-9. PubMed ID: 2280235
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction.
    Ullman B, Hulting J, Lundberg JM.
    Eur Heart J; 1994 Apr; 15(4):454-61. PubMed ID: 8070470
    [Abstract] [Full Text] [Related]

  • 3. Neuropeptide Y, noradrenaline and invasive haemodynamic data in mild to moderate chronic congestive heart failure.
    Ullman B, Jensen-Urstad M, Hulting J, Lundberg JM.
    Clin Physiol; 1993 Jul; 13(4):409-18. PubMed ID: 8370239
    [Abstract] [Full Text] [Related]

  • 4. Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure.
    Hulting J, Sollevi A, Ullman B, Franco-Cereceda A, Lundberg JM.
    Cardiovasc Res; 1990 Feb; 24(2):102-8. PubMed ID: 2328516
    [Abstract] [Full Text] [Related]

  • 5. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.
    Morris MJ, Russell AE, Kapoor V, Cain MD, Elliott JM, West MJ, Wing LM, Chalmers JP.
    J Auton Nerv Syst; 1986 Oct; 17(2):143-9. PubMed ID: 3782722
    [Abstract] [Full Text] [Related]

  • 6. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.
    Pernow J, Lundberg JM, Kaijser L, Hjemdahl P, Theodorsson-Norheim E, Martinsson A, Pernow B.
    Clin Physiol; 1986 Dec; 6(6):561-78. PubMed ID: 3466738
    [Abstract] [Full Text] [Related]

  • 7. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE, Lundberg JN, Weitzberg E.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [Abstract] [Full Text] [Related]

  • 8. Neuropeptide Y-like immunoreactivity and hypertension.
    Erlinge D, Ekman R, Thulin T, Edvinsson L.
    J Hypertens; 1992 Oct; 10(10):1221-5. PubMed ID: 1335004
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man.
    Edvinsson L, Ekman R, Thulin T.
    Regul Pept; 1991 Feb 26; 32(3):279-87. PubMed ID: 1866472
    [Abstract] [Full Text] [Related]

  • 11. Elevations of neuropeptide Y-like immunoreactivity and catecholamines in plasma on increased intracranial pressure in the pig.
    Rudehill A, Lundberg JM, Sollevi A, Hjemdahl P.
    Acta Anaesthesiol Scand; 1987 Feb 26; 31(2):132-8. PubMed ID: 3564869
    [Abstract] [Full Text] [Related]

  • 12. An animal and clinical study on the change of neuropeptide Y release evoked by electrical stimulation and myocardial ischemia.
    Cheng B, He Y, Xiang J, Guo L, Han Q.
    Chin Med J (Engl); 1999 May 26; 112(5):410-3. PubMed ID: 11593509
    [Abstract] [Full Text] [Related]

  • 13. The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.
    Hetland ML, Eldrup E, Bratholm P, Christensen NJ.
    Scand J Clin Lab Invest; 1991 May 26; 51(3):219-24. PubMed ID: 1909048
    [Abstract] [Full Text] [Related]

  • 14. Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure.
    Feng QP, Hedner T, Andersson B, Lundberg JM, Waagstein F.
    Br Heart J; 1994 Mar 26; 71(3):261-7. PubMed ID: 8142196
    [Abstract] [Full Text] [Related]

  • 15. Neuropeptide Y and sympathetic vascular control in man.
    Lundberg JM, Torssell L, Sollevi A, Pernow J, Theodorsson Norheim E, Anggård A, Hamberger B.
    Regul Pept; 1985 Dec 26; 13(1):41-52. PubMed ID: 3841402
    [Abstract] [Full Text] [Related]

  • 16. Neuropeptide Y-like immunoreactivity of plasma during hypoglycaemia in man.
    Russell AE, Cain MD, Kapoor V, Morris MJ, Chalmers JP.
    J Auton Nerv Syst; 1989 Feb 26; 26(1):85-8. PubMed ID: 2708787
    [Abstract] [Full Text] [Related]

  • 17. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.
    Pernow J, Lundberg JM, Kaijser L.
    J Cardiovasc Pharmacol; 1988 Feb 26; 12(5):593-9. PubMed ID: 2468060
    [Abstract] [Full Text] [Related]

  • 18. Exercise-induced changes in neuropeptide Y, noradrenaline and endothelin-1 levels in young people with type I diabetes.
    Ahlborg G, Lundberg JM.
    Clin Physiol; 1996 Nov 26; 16(6):645-55. PubMed ID: 8937803
    [Abstract] [Full Text] [Related]

  • 19. [Plasma levels of neuropeptide Y i patients with current myocardial infarction].
    Halawa B, Salomon P.
    Pol Arch Med Wewn; 2001 Feb 26; 105(2):117-22. PubMed ID: 11505745
    [Abstract] [Full Text] [Related]

  • 20. Effects of vinblastine on neuropeptide Y levels in the sympathoadrenal system, bone marrow and thrombocytes of the rat.
    Hemsén A, Pernow J, Millberg BI, Lundberg JM.
    Agents Actions; 1991 Nov 26; 34(3-4):429-38. PubMed ID: 1810152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.